Healthcare Finance, Tax & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advanced Magnetics, Inc.
Pharmaceutical firm reports loss of $0.32 per share
February 23rd, 2005
Advanced Magnetics, Inc., (AVM) announced operating results and revenues for the first fiscal quarter of 2005 ended December 31, 2004. Revenues for the quarter were $1,022,264 as compared to revenues of $631,964 for the same period in fiscal 2004. The company reported a net loss of $2,549,112 or $0.32 per share compared to a net loss of $940,700 or $0.12 per share for the same period in fiscal 2004. The loss in the quarter ended December 31, 2004, resulted primarily from an increase in research and development expenses related to the phase III clinical trials for ferumoxytol in iron replacement therapy. Cash, cash equivalents, and short-term and...
Source: Healthcare Finance, Tax & Law Weekly (2005-02-23)
|
